Product Code: GVR-4-68039-444-2
Patient Monitoring Devices Market Growth & Trends:
The global patient monitoring devices market size is expected to reach USD 92.8 billion by 2030 and is projected to grow at a CAGR of 7.8%, according to a new report by Grand View Research, Inc. The demand in the market is expected to rise owing to the technological advancements in patient monitoring devices along with the growth in the number of hospital admissions globally.
Improving healthcare expenditure across the globe coupled with the rising adoption of remote monitoring systems will also augment the market growth over the forecast period. Many hospitals and healthcare providers are investing in remote patient monitoring technologies as a part of a value-based care model.
Patient monitoring devices help in monitoring and managing high-risk patients that are suffering from chronic diseases and are considered unstable. There has been a rise in the prevalence of chronic diseases such as diabetes, cancer, and hypertension across the world. Over 100 million Americans have hypertension and an increased risk of heart disease, according to the Centers for Disease Control and Prevention (CDC). The need for patient monitoring devices is rising due to the increasing prevalence of these conditions worldwide.
COVID-19 has decreased frequent hospital visits while increasing demand for home monitoring devices. Additionally, the scenario has altered customer demand, buying patterns, and behavior. The necessity to harness and utilize digital infrastructure for remote patient monitoring has been brought into sharp relief by the COVID-19 outbreak. The combination of telehealth & remote patient monitoring is projected to enhance the provision of at-home healthcare.
Patient monitoring devices industry growth is also being driven by supporting activities by the public and private sectors to assist COVID-19 patients globally. For instance, the World Health Organization distributed 30,000 oxygen concentrations worldwide in February 2021. Similarly, Invacare Corporation saw sales of respiratory products increase by 72.2% in the fourth quarter of 2020.
Patient Monitoring Devices Market Report Highlights:
- Due to the technological advancements in multi-parameter patient monitoring, the category for multi-parameter monitoring devices accounted for the greatest revenue share of 23.3% in 2021. Multi-parameter patient monitors are widely used for enhancing the quality of healthcare in both the in-patient wards and intensive care units (ICU)
- The blood glucose monitoring devices segment is expected to show lucrative growth during the forecast period owing to the growing number of diabetic patients' demand for monitoring devices to keep track of their health
- Due to the strong demand for various monitoring devices to monitor patients at hospitals, the hospitals segment accounted for the largest revenue share of 51.1% in 2021
- North America contributed to the largest revenue share of 42.6% in 2021, owing to the presence of well-established reimbursement policies, dominant market players, high healthcare expenditure, and high adoption rate for advanced medical technologies
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product type
- 1.1.2. End-use type
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline.
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
- 1.9.3. Objective 3
- 1.9.4. Objective 4
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Patient Monitoring Devices Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Product Pipeline Analysis, by Stage
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Growing preference for wearable patient monitoring devices
- 3.4.1.2. Increasing prevalence of chronic disease
- 3.4.2. Market restraint analysis
- 3.4.2.1. Risk associated with invasive monitoring devices
- 3.4.3. Industry challenges
- 3.5. Patient Monitoring Devices: Market Analysis Tools
- 3.5.1. Industry analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat from new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Environmental landscape
- 3.5.2.3. Social landscape
- 3.5.2.4. Technology landscape
- 3.5.2.5. Legal landscape
- 3.5.3. Major deals & strategic alliances analysis
Chapter 4. Patient Monitoring Devices Market: Segment Analysis, by Product Type, 2018 - 2030 (USD Billion)
- 4.1. Segment Dashboard
- 4.2. Product type Market Share Analysis, 2021 & 2030
- 4.3. Global Patient Monitoring Devices Market, by Product Type, 2018 to 2030
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
- 4.4.1. Blood Glucose Monitoring Systems
- 4.4.1.1. Self-monitoring blood glucose systems
- 4.4.1.2. Continuous Glucose Monitoring System
- 4.4.2. Cardiac Monitoring Devices
- 4.4.2.1. ECG Devices
- 4.4.2.2. Implantable Loop Records
- 4.4.2.3. Event Monitors
- 4.4.2.4. Mobile Cardiac Telemetry Monitors
- 4.4.2.5. Smart/Wearable ECG Monitors
- 4.4.3. Multi-parameter Monitoring Devices.
- 4.4.3.1. Low-acuity Monitoring Devices
- 4.4.3.2. Mid-acuity Monitoring Devices
- 4.4.3.3. High-acuity Monitoring Devices
- 4.4.4. Respiratory Monitoring Devices
- 4.4.4.1. Pulse Oximeters
- 4.4.4.2. Spirometer
- 4.4.4.3. Capnographs
- 4.4.4.4. Peak Flow Meters
- 4.4.5. Temperature Monitoring Devices
- 4.4.5.1. Handheld Temperature Monitoring Devices
- 4.4.5.2. Table-top Temperature Monitoring Devices
- 4.4.5.3. Wearable Continuous Monitoring Devices
- 4.4.5.4. Invasive Temperature Monitoring Devices
- 4.4.6. Smart Temperature Monitoring Devices
- 4.4.7. Hemodynamic/ Pressure Monitoring Devices
- 4.4.7.1. Hemodynamic Monitoring Devices
- 4.4.7.2. Blood Pressure Monitors
- 4.4.7.3. Disposable
- 4.4.8. Fetal & Neonatal Monitoring Devices
- 4.4.8.1. Fetal Monitoring Devices
- 4.4.8.2. Neonatal Monitoring Devices
- 4.4.9. Neuromonitoring Devices
- 4.4.9.1. Electroencephalograph Machines
- 4.4.9.2. Electromyography Machines
- 4.4.9.3. Cerebral Oximeters
- 4.4.9.4. Intracranial Pressure Monitors
- 4.4.9.5. Magnetoencephalograph Machines
- 4.4.9.6. Transcranial Doppler Machines
- 4.4.10. Weight Monitoring Devices
- 4.4.10.1. Digital
- 4.4.10.2. Analog
- 4.4.11. Other Patient Monitoring Devices
Chapter 5. Patient Monitoring Devices Market: Segment Analysis, By End-use, 2018 - 2030 (USD Billion)
- 5.1. Segment Dashboard
- 5.2. End-use Market Share Analysis, 2021 & 2030
- 5.3. Patient Monitoring Device Market, By End-Use, 2018 to 2030
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4.1. Hospitals
- 5.4.2. Ambulatory Surgery Centers
- 5.4.3. Home Care Settings
- 5.4.4. Other
Chapter 6. Patient Monitoring Devices Market: Regional Market Analysis, by Product Type, 2018 - 2030 (USD Billion)
- 6.1. Regional Market Share Analysis, 2021 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030
- 6.4. North America
- 6.4.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
- 6.4.2. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.4.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.4.4. U.S.
- 6.4.4.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.4.4.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.4.5. Canada
- 6.4.5.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.4.5.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.5. Europe
- 6.5.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
- 6.5.2. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.5.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.5.4. Germany
- 6.5.4.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.5.4.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.5.5. U.K.
- 6.5.5.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.5.5.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.5.6. France
- 6.5.6.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.5.6.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.5.7. Italy
- 6.5.7.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.5.7.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.5.8. Spain
- 6.5.8.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.5.8.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.6. Asia Pacific
- 6.6.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
- 6.6.2. Market estimates and forecast, By product type, 2018 - 2030 (USD Billion)
- 6.6.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.6.4. China
- 6.6.4.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.6.4.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.6.5. Japan
- 6.6.5.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.6.5.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.6.6. India
- 6.6.6.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.6.6.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.7. Latin America
- 6.7.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
- 6.7.2. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.7.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.7.4. Brazil
- 6.7.4.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.7.4.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.7.5. Mexico
- 6.7.5.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.7.5.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.7.6. Argentina
- 6.7.6.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.7.6.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.7.7. Colombia
- 6.7.7.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.7.7.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.8. Middle East and Africa
- 6.8.1. Market estimates and forecast, by country, 2018 - 2030 (USD Billion)
- 6.8.2. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.8.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.8.4. South Africa
- 6.8.4.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.8.4.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.8.5. Saudi Arabia
- 6.8.5.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.8.5.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
- 6.8.6. UAE
- 6.8.6.1. Market estimates and forecast, by product type, 2018 - 2030 (USD Billion)
- 6.8.6.2. Market estimates and forecast, by end-use, 2018 - 2030 (USD Billion)
Chapter 7. Patient Monitoring Devices Market - Competitive Analysis
- 7.1. Key Company Profiles
- 7.1.1. Honeywell
- 7.1.1.1. Company overview
- 7.1.1.2. Financial performance
- 7.1.1.3. Product benchmarking
- 7.1.1.4. Strategic initiatives
- 7.1.2. American Telecare
- 7.1.2.1. Company overview
- 7.1.2.2. Financial performance
- 7.1.2.3. Product benchmarking
- 7.1.2.4. Strategic initiatives
- 7.1.3. Roche
- 7.1.3.1. Company overview
- 7.1.3.2. Financial performance
- 7.1.3.3. Product benchmarking
- 7.1.3.4. Strategic initiatives
- 7.1.4. Philips Healthcare
- 7.1.4.1. Company overview
- 7.1.4.2. Financial performance
- 7.1.4.3. Product benchmarking
- 7.1.4.4. Strategic initiatives
- 7.1.5. Bosch
- 7.1.5.1. Company overview
- 7.1.5.2. Financial performance
- 7.1.5.3. Product benchmarking
- 7.1.5.4. Strategic initiatives
- 7.1.6. Biotronik
- 7.1.6.1. Company overview
- 7.1.6.2. Financial performance
- 7.1.6.3. Product benchmarking
- 7.1.6.4. Strategic initiatives
- 7.1.7. Koninklijke Philips N.V.
- 7.1.7.1. Company overview
- 7.1.7.2. Financial performance
- 7.1.7.3. Product benchmarking
- 7.1.7.4. Strategic initiatives
- 7.1.8. GE Healthcare
- 7.1.8.1. Company overview
- 7.1.8.2. Financial performance
- 7.1.8.3. Product benchmarking
- 7.1.8.4. Strategic initiatives
- 7.1.9. Medtronic
- 7.1.9.1. Company overview
- 7.1.9.2. Financial performance
- 7.1.9.3. Product benchmarking
- 7.1.9.4. Strategic initiatives
- 7.1.10. Masimo Corporation
- 7.1.10.1. Company overview
- 7.1.10.2. Financial performance
- 7.1.10.3. Product benchmarking
- 7.1.10.4. Strategic initiatives
- 7.1.11. Smiths Medical
- 7.1.11.1. Company overview
- 7.1.11.2. Financial performance
- 7.1.11.3. Product benchmarking
- 7.1.11.4. Strategic initiatives